Source: Recursion Pharmaceuticals AI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone. Recursion was able to use its artificial intelligence-enabled drug discovery platform to identify an area of biology to target for the treatment of solid tumors and lymphoma, match it with a drug candidate and move … Read more
U.S. crude oil rose nearly 3% on Wednesday as traders fear Israel could target Iran’s oil infrastructure in retaliation for a ballistic missile attack. Israel’s ambassador to the United Nations, Danny Danon, vowed late Tuesday that Israel will exact a “painful” response against Iran. Danon’s threat came hours after the Islamic Republic launched around 180 … Read more
Alvaro Gonzalez | Moment | Getty Images Whether it’s stock market volatility, the Federal Reserve’s interest rate cuts or proposed tax law changes, we’re dedicated to breaking down the news to help investors make smart money decisions. But CNBC’s personal finance team also recognizes the value of financial planning, regardless of your life stage, income … Read more
As heightened tensions in the Middle East sent the major averages tumbling on Tuesday, CNBC’s Jim Cramer reminded investors about the market’s solid performance over the past quarter. He suggested the market has broadened considerably beyond Big Tech and reviewed the top performers on the S&P 500, saying the past three months saw “the revenge … Read more
Jonathan Raa | Nurphoto | Getty Images Cryptocurrencies slid on Tuesday night, with bitcoin dropping back to the $60,000 level after a shaky start to what is usually one of its strongest months. The flagship crypto was last off by nearly 4% at $60,972.62, according to Coin Metrics. Around 4:45 p.m. Eastern time, bitcoin slid … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks are starting the first day of October and the fourth quarter on a lower note, following a similar trend we saw at the start … Read more
Vice President Kamala Harris further positioned herself as a pro-cannabis candidate on Monday in an interview with sports and culture podcast “All the Smoke” — but industry leaders aren’t convinced her administration would lead to the reform she has promised. “I just think we have come to a point where we have to understand that … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Stocks are lower to start October following a strong month of gains in historically weak September. The Nasdaq fell about 1.5%, while the S & P 500 lost nearly … Read more
U.S. crude oil prices rose nearly 3% on Tuesday, as the U.S. warned of a possible imminent attack by Iran against Israel. Senior White House and Defense Department officials told NBC News that the U.S. “has indications that Iran is preparing to imminently launch a ballistic missile attack against Israel.” “We are actively supporting defensive … Read more
Charles Schwab CEO Walt Bettinger is retiring from his role at the end of December after 16 years leading the brokerage firm, the company announced Tuesday. Bettinger will be replaced on Jan. 1, 2025, by Charles Schwab President Rick Wurster. Bettinger will remain as the co-chair of Schwab’s board. Stock Chart IconStock chart icon Charles … Read more
